A multicentre phase III study comparing efficacy & safety of novel extended-release vs. conventional formulation of Dydrogesterone in Indian patients with endometriosis

In: Research Square · 2024 · doi:10.21203/rs.3.rs-4121316/v1 · W4394950795
preprint OA: green CC0
📄 Open PDF View on OpenAlex View at publisher

My notes (saved in your browser only)

Outcome instruments

VAS-pain

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Source provenance

europepmc
last seen: 2026-06-04T01:45:00.660873+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK